中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:(Yali ZHAN)

1.Quality standard for Ershiwuwei Feibing Pills

Xiang LI ; Yali LIU ; Pei QIAO ; Jing ZHANG ; Zhiqing LIU ; Qin HUANG ; Jing CHEN ; Chunfeng ZHAN

Chinese Traditional Patent Medicine 2017;39(7):1410-1414

2.Clinical epidemiological characteristics and prognostic risk factors in 2 245 patients with hemorrhagic fever with renal syndrome

Haifeng HU ; Jiayi ZHAN ; Hong DU ; Yali YANG ; Fei HU ; Jiayu LI ; Zhanhu BI ; Xiaofei YANG ; Yan LIANG ; Jianqi LIAN

Chinese Journal of Infectious Diseases 2023;41(1):70-76

3.Correlation between pathological types of parathyroid and clinical manifestations in patients with renal secondary hyperparathyroidism

Yali ZHAN ; Xiaohe WANG ; Deguang WANG ; Sen ZHANG ; Yang WAN ; Jifeng WU ; Shengxue XIE ; Li HAO

Chinese Journal of Nephrology 2018;34(3):179-184

4.Effectiveness of the "14 plus 7 day quarantine" and "nucleic acid plus total antibody testing" strategy for screening imported patients with COVID-19 in Xiamen

Litong SHEN ; Zhenhua DUAN ; Zehui CHEN ; Tianci YANG ; Tao LIN ; Rongqiu ZHANG ; Lina JIANG ; Xiaohong ZENG ; Huixin WEN ; Qinyong ZHAN ; Yingying SU ; Yali ZHANG ; Zhibin PENG ; Jiandong ZHENG ; Rongrong ZHENG ; Ying QIN ; Quan YUAN ; Changrong CHEN

Chinese Journal of Epidemiology 2021;42(6):1002-1007

5.Hypericin reduces myocardial ischemia-reperfusion injury in rats by modulating AMPK/Nrf2/HO-1 signaling pathway

Huihui LI ; ANWER GULINIGAER ; Xiaofeng GAO ; Gang WANG ; Yali BAO ; Tian ZHANG ; AINIWAR DINA ; Can LING ; Zhan SUN

Chinese Journal of Pathophysiology 2024;40(10):1882-1890

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO